Andrew Orth

No open positions remaining

Net worth: 24 M $ as of 30/09/2026

56 year

Health Technology

Consumer Services

Profile

Mr. Andrew C.
Orth is a President, Chief Executive Officer & Director at City Therapeutics, Inc. He is on the Board of Directors at City Therapeutics, Inc. Mr. Orth was previously employed as a Chief Commercial Officer by Krystal Biotech, Inc. and a Senior Vice President & Head-US Busines by Alnylam Pharmaceuticals, Inc. He received his undergraduate degree from the University of Wisconsin and an MBA from Johnson Graduate School of Management.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
2.06%	19/10/2026	1,063,154 ( 2.06% )	24 M $	30/09/2026

Andrew Orth active positions

Companies	Position	Start

All active positions of Andrew Orth

Former positions of Andrew Orth

Companies	Position	End
KRYSTAL BIOTECH, INC.	Corporate Officer/Principal	02/08/2023
BIOGEN INC.	Corporate Officer/Principal	01/01/2016
ALNYLAM PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Andrew Orth's experience

Education of Andrew Orth

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Orth's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference	Health Technology
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Johnson Graduate School of Management Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Krystal Biotech, Inc. Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases	Health Technology